Collaborative Drug Therapy Agreement (CDTA) for Influenza Antivirals in Washington State

A team from the Washington State Pharmacy Association (WSPA), NWCPHP, and PHSKC developed a template Collaborative Drug Therapy Agreement (CDTA) for Influenza Antiviral Medications under a contract with WA State DOH, supported via CDC pandemic preparedness funds. The product of this collaboration is available here, for use by local health officers and by individual authorized prescribers to allow pharmacists to prescribe antiviral medications in case of an influenza outbreak. Although the Collaborative Drug Therapy Agreement may be entered into at any time and submitted to the Washington State Board of Pharmacy, the protocol is intended only to go into effect when authorized by local health officers. The guidance provided here will be updated frequently during an outbreak, so it is important for pharmacists to check these Web sites often for updates:

Web Sites

CDC's H1N1 Flu Updates
Washington State Department of Health
Your local health department's Web site (e.g., http://www.kingcounty.gov/healthservices/health/preparedness/pandemicflu/swineflu.aspx)

Template CDTA

Collaborative Drug Therapy Agreement
This CDTA is for use by local health officers or by authorized prescribers and pharmacists to enter into an agreement to allow pharmacists to prescribe and dispense antiviral medications for influenza, in case of an outbreak.

Training Materials for Pharmacists

Flu CDTA Training Presentation
This training module must be viewed by pharmacists before they begin prescribing and dispensing antiviral medications for influenza. The slides may also be printed out and kept as a reference in the pharmacy.

Self-Assessment Quiz
The self-assessment quiz should be completed by pharmacists after viewing the training module. It may be submitted to WSPA by FAX for one (1) hour of Continuing Education credit (0.1 CEU).

Washington State Pharmacy Association
411 Williams Ave S
Renton, WA 98057
Phone: 425-228-7171
FAX: 425-277-3897
mlieggi@wsparx.org

Screening Form Template

Screening Form Template
This screening form template may be used as is or altered depending on the requirements of the local health office that has authorized prescribing and dispensing of influenza antiviral medications. Screening forms should be completed and submitted and/or filed as directed by local health officers.

Toolkit

The materials in the toolkit can help pharmacists properly prescribe antiviral medications. For questions or further information, please contact Jenny Arnold at jarnold@wsparx.org or Andy Stergachis at stergach@uw.edu.

Additional Prescribing Information for Antivirals

Prescribing and Dispensing Algorithm for Prophylaxis with Oseltamivir (TAMIFLU)

Prescribing and Dispensing Algorithm for Prophylaxis with Zanamivir (RELENZA)

Prescribing and Dispensing Algorithm for Treatment with Oseltamivir (TAMIFLU)

Prescribing and Dispensing Algorithm for Treatment with Zanamivir (RELENZA)

Taking Temperatures in the Pharmacy

Please note: This Collaborative Drug Therapy Agreement only covers the prescription of antiviral medications for influenza. Local Health Officers and pharmacists should be aware that the H1N1 Vaccine is covered under the Immunization Collaborative Agreement for pharmacists, which can be found on the Board of Pharmacy's Web site.

Skip to content. \| Skip to navigation Search Site Advanced Search… Sections Home Partners Training Research Evaluation News & Events Resources Publications About
Navigation Online Courses In-Person Tabletop Exercises Hot Topics Summer Institute Leadership Institute Degree & Certificate Programs Other Resources PH LearnLink Help iLinc Help	Info Collaborative Drug Therapy Agreement (CDTA) for Influenza Antivirals in Washington State A team from the Washington State Pharmacy Association (WSPA), NWCPHP, and PHSKC developed a template Collaborative Drug Therapy Agreement (CDTA) for Influenza Antiviral Medications under a contract with WA State DOH, supported via CDC pandemic preparedness funds. The product of this collaboration is available here, for use by local health officers and by individual authorized prescribers to allow pharmacists to prescribe antiviral medications in case of an influenza outbreak. Although the Collaborative Drug Therapy Agreement may be entered into at any time and submitted to the Washington State Board of Pharmacy, the protocol is intended only to go into effect when authorized by local health officers. The guidance provided here will be updated frequently during an outbreak, so it is important for pharmacists to check these Web sites often for updates: Web Sites CDC's H1N1 Flu Updates Washington State Department of Health Your local health department's Web site (e.g., http://www.kingcounty.gov/healthservices/health/preparedness/pandemicflu/swineflu.aspx) Template CDTA Collaborative Drug Therapy Agreement This CDTA is for use by local health officers or by authorized prescribers and pharmacists to enter into an agreement to allow pharmacists to prescribe and dispense antiviral medications for influenza, in case of an outbreak. Training Materials for Pharmacists Flu CDTA Training Presentation This training module must be viewed by pharmacists before they begin prescribing and dispensing antiviral medications for influenza. The slides may also be printed out and kept as a reference in the pharmacy. Self-Assessment Quiz The self-assessment quiz should be completed by pharmacists after viewing the training module. It may be submitted to WSPA by FAX for one (1) hour of Continuing Education credit (0.1 CEU). Washington State Pharmacy Association 411 Williams Ave S Renton, WA 98057 Phone: 425-228-7171 FAX: 425-277-3897 mlieggi@wsparx.org Screening Form Template Screening Form Template This screening form template may be used as is or altered depending on the requirements of the local health office that has authorized prescribing and dispensing of influenza antiviral medications. Screening forms should be completed and submitted and/or filed as directed by local health officers. Toolkit The materials in the toolkit can help pharmacists properly prescribe antiviral medications. For questions or further information, please contact Jenny Arnold at jarnold@wsparx.org or Andy Stergachis at stergach@uw.edu. Additional Prescribing Information for Antivirals Prescribing and Dispensing Algorithm for Prophylaxis with Oseltamivir (TAMIFLU) Prescribing and Dispensing Algorithm for Prophylaxis with Zanamivir (RELENZA) Prescribing and Dispensing Algorithm for Treatment with Oseltamivir (TAMIFLU) Prescribing and Dispensing Algorithm for Treatment with Zanamivir (RELENZA) Taking Temperatures in the Pharmacy Please note: This Collaborative Drug Therapy Agreement only covers the prescription of antiviral medications for influenza. Local Health Officers and pharmacists should be aware that the H1N1 Vaccine is covered under the Immunization Collaborative Agreement for pharmacists, which can be found on the Board of Pharmacy's Web site.